Default company panoramic image
Logo

Adarza BioSystems, Inc.

Adarza has developed a revolutionary label-free, microarray immunoassay platform for measuring biomarkers in research and clinical samples.

  • Stage Product In Development
  • Industry Biotechnology
  • Location West Henrietta, NY, USA
  • Currency USD
  • Founded January 2008
  • Employees 7
  • Website adarzabio.com

Company Summary

Adarza is developing a next generation multiplex immunoassay platform that overcomes the multiplex, workflow, and throughput limitations of current products. Adarza will meet or exceed current gold standard performance levels with a label-free platform that substantially reduces the number of process steps. No research or diagnostic product currently exists that can achieve this level of multiplexing while maintaining high sensitivity.

Team

  • Default avatar
    James Senall
    Director

    President of High Tech Rochester

  • Default avatar
    Randolph R. Henke
    CEO, Board Chair, Founder

    Over 30 years of executive management and R&D development experience.

  • Default avatar
    Teryl Gronwall
    COO, Founder

    Over 30 years of executive management and R&D development experience.

  • Default avatar
    Christopher Striemer
    VP Engineering, Director, Founder

    Over 15 years of optical/electrical engineering R&D experience.

  • Default avatar
    Heiner Dreismann
    Director

    Past CEO of Roche Molecular, over 30 years of IVD experience.

  • Default avatar
    Tod Woolf
    Advisory Board member

    Technology/Product Development Advisor
    Over 25 years of biomedical technology development experience.

  • Default avatar
    Benjamin Miller
    Director, Advisory Board Chair, Founder

    University of Rochester Medical Center, Over 20 years of research and R&D management experience.

  • Default avatar
    Martin Brusdeilins
    Advisory Board Member

    , Product Manufacturing and Business Advisor;
    EVP, Head of Devel. & Operations, Tecan Group, Ltd., Past VP for R&D, Ortho Clinical Diagnostics

  • Default avatar
    David Smoller
    Advisory Board Member

    Technology, Product and Business Advisor; Past CSO Sigma Aldrich, Past CEO ProteoPlex

  • Default avatar
    Charles Mace
    Advisory Board Member

    Assay Development Advisor;
    Past AIR researcher, Harvard University

Advisors

  • Default avatar
    Thomas Anderson, Harter Secrest & Emery LLP
    Lawyer
    Unconfirmed
    Default avatar
    David Vanisky EFP Rotenberg LLP
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Excell Partners, Inc.
    Unconfirmed
    Default avatar
    Rochester, New York
    Unconfirmed